The use of chitosan formulations in cancer therapy

References

• Alivisatos AP, Johnsson KP, Peng X, Wilson TE, Loweth CJ, Bruchez MP Jr, Schultz PG. Organization of ‘nanocrystal molecules’ using DNA. Nature 1996; 382: 609–611
   PubMed Web of Science ®Google Scholar
• Allen TM, Cullis PR. Drug delivery systems: Entering the mainstream. Science 2004; 303: 1818–1822
   PubMed Web of Science ®Google Scholar
• Chen WR, Adams RL, Carubelli R, Nordquist RE. Laser-photosensitizer assisted immunotherapy: A novel modality for cancer treatment. Cancer Lett 1997; 115: 25–30
   PubMed Web of Science ®Google Scholar
• Dass CR. Oligonucleotide delivery to tumours using macromolecular agents. Biotech Appl Biochem 2004a; 40: 113–122
   PubMed Web of Science ®Google Scholar
• Dass CR. Lipoplex-mediated delivery of nucleic acids: Factors affecting in vivo transfection. J Mol Med 2004b; 82: 579–591
   PubMed Web of Science ®Google Scholar
• Dass CR, Burton MA. A modified microplex vector enhances transfection of cells in culture while maintaining its tumour-selective gene delivery in vivo. J Pharm Pharmacol 2003; 55: 19–25
   PubMed Web of Science ®Google Scholar
• Dass CR, Contreras KG, Dunstan DE, Choong PF. Chitosan microparticles encapsulating PEDF plasmid demonstrate efficacy in an orthotopic metastatic model of osteosarcoma. Biomaterials 2007; 28: 3026–3033
   PubMed Web of Science ®Google Scholar
• Dass CR, Ek ET, Contreras KG, Choong PF. A novel orthotopic murine model provides insights into cellular and molecular characteristics contributing to human osteosarcoma. Clin Exp Metastasis 2006; 23: 367–380
   PubMed Web of Science ®Google Scholar
• Dass CR, Saravolac EG, Li Y, Sun LQ. Cellular uptake, distribution, and stability of 10-23 deoxyribozymes. Antisense Nucleic Acid Drug Dev 2002; 12: 289–299
   PubMedGoogle Scholar
• Dass CR, Walker TL, Kalle WHJ, Burton MA. A microsphere-lipoplex (microplex) vector for targeted gene therapy of cancer. II. In vivo biodistribution study in a solid tumour model. Drug Deliv 2000; 7: 15–20
   PubMed Web of Science ®Google Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. Inhibition of orthotopic osteosarcoma growth and metastasis by multitargeted antitumor activities of pigment epithelium-derived factor. Clin Exp Mets 2007a; 24: 93–106
   PubMed Web of Science ®Google Scholar
• Ek ET, Dass CR, Contreras KG, Choong PF. PEDF peptides inhibit osteosarcoma growth and metastasis in mice. J Orthop Res 2007b; 25, Jun 28 epub ahead of print
   PubMedGoogle Scholar
• Gabizon A, Shmeeda H, Barenholz Y. Pharmacokinetics of pegylated liposomal Doxorubicin: Review of animal and human studies. Clin Pharmacokinet 2003; 42: 419–436
   PubMed Web of Science ®Google Scholar
• Guminska M, Ignacak J, Wojcik E. In vitro inhibitory effect of chitosan and its degradation products on energy metabolism in Ehrlich ascites tumour cells (EAT). Polish J Pharmacol 1996; 48: 495–501
   PubMedGoogle Scholar
• Hasegawa M, Yagi K, Iwakawa S, Hirai M. Chitosan induces apoptosis via caspase-3 activation in bladder tumor cells. Jpn J Cancer Res 2001; 92: 459–466
   PubMedGoogle Scholar
• Howard KA, Rahbek UL, Liu X, Damgaard CK, Glud SZ, Andersen MO, Hovgaard MB, Schmitz A, Nyengaard JR, Besenbacher F, Kjems J. RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. Mol Ther 2006; 14: 476–484
   PubMed Web of Science ®Google Scholar
• Ishii T, Okahata Y, Sato T. Mechanism of cell transfection with plasmid/chitosan complexes. Biochim Biophys Acta 2001; 1514: 51–64
   PubMed Web of Science ®Google Scholar
• Kaiser J. Clinical research. Death prompts a review of gene therapy vector. Science 2007; 317: 580
   PubMed Web of Science ®Google Scholar
• Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J Cont Rel 2006; 115: 216–225
   PubMed Web of Science ®Google Scholar
• Kim TH, Jin H, Kim HW, Cho MH, Cho CS. Mannosylated chitosan nanoparticle-based cytokine gene therapy suppressed cancer growth in BALB/c mice bearing CT-26 carcinoma cells. Mol Cancer Ther 2006; 5: 1723–1732
   PubMed Web of Science ®Google Scholar
• Koshkina NV, Agoulnik IY, Melton SL, Densmore CL, Knight V. Biodistribution and pharmacokinetics of aerosol and intravenously administered DNA-polyethyleneimine complexes: Optimization of pulmonary delivery and retention. Mol Ther 2003; 8: 249–254
   PubMed Web of Science ®Google Scholar
• Leong KW, Mao HQ, Truong-Le VL, Roy K, Walsh SM, August JT. DNA-polycation nanospheres as non-viral gene delivery vehicles. J Cont Rel 1998; 53: 183–93
   PubMed Web of Science ®Google Scholar
• Lin SY, Chan HY, Shen FH, Chen MH, Wang YJ, Yu CK. Chitosan prevents the development of AOM-induced aberrant crypt foci in mice and suppressed the proliferation of AGS cells by inhibiting DNA synthesis. J Cell Biochem 2007; 100: 1573–1580
   PubMed Web of Science ®Google Scholar
• Liu X, Howard KA, Dong M, Andersen MO, Rahbek UL, Johnsen MG, Hansen OC, Besenbacher F, Kjems J. The influence of polymeric properties on chitosan/siRNA nanoparticle formulation and gene silencing. Biomaterials 2007; 28: 1280–1288
   PubMed Web of Science ®Google Scholar
• Marwick C. First ‘antisense’ drug will treat CMV retinitis. JAMA 1998; 280: 871
   PubMed Web of Science ®Google Scholar
• Mathiowitz E, Jacob JS, Jong YS, Carino GP, Chickering DE, Chaturvedi P, Santos CA, Vijayaraghavan K, Montgomery S, Bassett M, et al. Biologically erodable microspheres as potential oral drug delivery systems. Nature 1997; 386: 410–414
   PubMed Web of Science ®Google Scholar
• Mirkin CA, Letsinger RL, Mucic RC, Storhoff JJ. A DNA-based method for rationally assembling nanoparticles into macroscopic materials. Nature 1996; 382: 607–609
   PubMed Web of Science ®Google Scholar
• Murata J, Saiki I, Nishimura S, Nishi N, Tokura S, Azuma I. Inhibitory effect of chitin heparinoids on the lung metastasis of B16-BL6 melanoma. Jpn J Cancer Res 1989; 80: 866–872
   PubMedGoogle Scholar
• Nishimura K, Nishimura S, Nishi N, Saiki I, Tokura S, Azuma I. Immunological activity of chitin and its derivatives. Vaccine 1984; 2: 93–99
   PubMedGoogle Scholar
• Northfelt DW, Martin FJ, Working P, Volberding PA, Russell J, Newman M, Amantea MA, Kaplan LD. Doxorubicin encapsulated in liposomes containing surface-bound polyethylene glycol: pharmacokinetics, tumor localization, and safety in patients with AIDS-related Kaposi's sarcoma. J Clin Pharmacol 1996; 36: 55–63
   PubMed Web of Science ®Google Scholar
• Ozbas-Turan S, Aral C, Kabasakal L, Keyer-Uysal M, Akbuga J. Co-encapsulation of two plasmids in chitosan microspheres as a non-viral gene delivery vehicle. J Pharm Pharm Sci 2003; 6: 27–32
   PubMed Web of Science ®Google Scholar
• Peters BG, Goeckner BJ, Ponzillo JJ, Velasquez WS, Wilson AL. Pegaspargase versus asparaginase in adult ALL: A pharmacoeconomic assessment. Formulary 1995; 30: 388–393
   PubMed Web of Science ®Google Scholar
• Picard FJ, Bergeron MG. Rapid molecular theranostics in infectious diseases. Drug Discov Today 2002; 7: 1092–1101
   PubMed Web of Science ®Google Scholar
• Pille JY, Li H, Blot E, Bertrand JR, Pritchard LL, Opolon P, Maksimenko A, Lu H, Vannier JP, Soria J, Malvy C, Soria C. Intravenous delivery of anti-RhoA small interfering RNA loaded in nanoparticles of chitosan in mice: Safety and efficacy in xenografted aggressive breast cancer. Hum Gene Ther 2006; 17: 1019–1026
   PubMed Web of Science ®Google Scholar
• Qi L, Xu Z, Chen M. In vitro and in vivo suppression of hepatocellular carcinoma growth by chitosan nanoparticles. Eur J Cancer 2007; 43: 184–193
   PubMed Web of Science ®Google Scholar
• Redorbit. 2007, Available online at: http://www.redorbit.com/news/health/696002/gentas_gentasense_gets_orphan_status/index.html, accessed 10 May 2007
   Google Scholar
• Roy K, Mao HQ, Huang SK, Leong KW. Oral gene delivery with chitosan-DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5: 387–391
   PubMed Web of Science ®Google Scholar
• Saiki I, Murata J, Nakajima M, Tokura S, Azuma I. Inhibition by sulfated chitin derivatives of invasion through extracellular matrix and enzymatic degradation by metastatic melanoma cells. Cancer Res 1990; 50: 3631–3637
   PubMed Web of Science ®Google Scholar
• Smith DH, Adams JR, Johnston SR, Gordon A, Drummond MF, Bennett CL. A comparative economic analysis of pegylated liposomal doxorubicin versus topotecan in ovarian cancer in the USA and the UK. Ann Oncol 2002; 13: 1590–1597
   PubMed Web of Science ®Google Scholar
• Springate CM, Jackson JK, Gleave ME, Burt HM. Efficacy of an intratumoral controlled release formulation of clusterin antisense oligonucleotide complexed with chitosan containing paclitaxel or docetaxel in prostate cancer xenograft models. Cancer Chemother Pharmacol 2005; 56: 239–247
   PubMed Web of Science ®Google Scholar
• Tan WB, Jiang S, Zhang Y. Quantum-dot based nanoparticles for targeted silencing of HER2/neu gene via RNA interference. Biomaterials 2007; 28: 1565–1571
   PubMed Web of Science ®Google Scholar
• Thanou M, Florea BI, Geldof M, Junginger HE, Borchard G. Quaternized chitosan oligomers as novel gene delivery vectors in epithelial cell lines. Biomaterials 2002; 23: 153–159
   PubMed Web of Science ®Google Scholar
• Tokoro A, Tatewaki N, Suzuki K, Mikami T, Suzuki S, Suzuki M. Growth-inhibitory effect of hexa-N-acetylchitohexaose and chitohexaose against Meth-A solid tumor. Chem Pharm Bull (Tokyo) 1988; 36: 784–790
   PubMed Web of Science ®Google Scholar
• Zheng F, Shi XW, Yang GF, Gong LL, Yuan HY, Cui YJ, Wang Y, Du YM, Li Y. Chitosan nanoparticle as gene therapy vector via gastrointestinal mucosa administration: results of an in vitro and in vivo study. Life Sci 2007; 80: 388–396
   PubMed Web of Science ®Google Scholar